pentobarbital will lessen the extent or outcome of cannabidiol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Intently. Take into account an increase in cannabidiol dosage (based upon medical reaction and tolerability) when coadministered with a strong CYP3A4 inducer.Contraindicated (1)pentobarbital will lessen t